Ignite Creation Date:
2024-05-05 @ 7:32 PM
Last Modification Date:
2024-10-26 @ 9:49 AM
Study NCT ID:
NCT00683579
Status:
COMPLETED
Last Update Posted:
2017-02-28
First Post:
2008-05-21
Brief Title:
Neurocognitive Assessment in Youth Initiating HAART
Sponsor:
University of North Carolina Chapel Hill
Organization:
University of North Carolina Chapel Hill
Study Overview
Official Title:
Neurocognitive Assessment in Youth Initiating HAART
Status:
COMPLETED
Status Verified Date:
2016-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
ATN 071 is a prospective cohort study comparing neurocognitive functioning in four groups of youth age 18-24 Two groups with CD4 T cells above 350 cellsmm3 and HIV RNA 1000 copiesml one initiating HAART Group 1 and the other not initiating treatment Group 2 and two groups with CD4 T cells 350 cellsmm3 one initiating treatment Group 3 and the other not initiating treatment Group 4 Groups 2 and 3 represent standard of care Group 1 and a portion of group 2 will be co-enrolled in ATN 061 and will be randomly assigned to group by that protocol
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None